换一批A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.
第一作者：
Anoushka P,Lal
第一单位：
Department of Neuroscience, Central Clinical School, The Alfred, Melbourne, VIC, Australia.;Department of Neurology, The Alfred Hospital, 55 Commercial Road, Melbourne, 3004, Australia.
作者：
Anoushka P,Lal [1]
;
Yi Chao,Foong [2]
;
Paul G,Sanfilippo [3]
;
Tim,Spelman [3]
;
Louise,Rath [3]
;
David,Levitz [3]
;
Marzena,Fabis-Pedrini [4]
;
Matteo,Foschi [5]
;
Mario,Habek [6]
;
Tomas,Kalincik [7]
;
Izanne,Roos [8]
;
Jeannette,Lechner-Scott [9]
;
Nevin,John [10]
;
Aysun,Soysal [11]
;
Emanuele,D'Amico [12]
;
Riadh,Gouider [13]
;
Saloua,Mrabet [13]
;
Katrin,Gross-Paju [14]
;
Simón,Cárdenas-Robledo [15]
;
Abdorreza Naser,Moghadasi [16]
;
Maria Jose,Sa [17]
;
Orla,Gray [18]
;
Jiwon,Oh [19]
;
Stephen,Reddel [20]
;
Sudarshini,Ramanathan [21]
;
Talal,Al-Harbi [22]
;
Ayse,Altintas [23]
;
Todd A,Hardy [20]
;
Serkan,Ozakbas [24]
;
Raed,Alroughani [25]
;
Allan G,Kermode [4]
;
Andrea,Surcinelli [26]
;
Guy,Laureys [27]
;
Sara,Eichau [28]
;
Alexandre,Prat [29]
;
Marc,Girard [29]
;
Pierre,Duquette [29]
;
Suzanne,Hodgkinson [30]
;
Cristina,Ramo-Tello [31]
;
Davide,Maimone [32]
;
Pamela,McCombe [33]
;
Daniele,Spitaleri [34]
;
Jose Luis,Sanchez-Menoyo [35]
;
Mehmet Fatih,Yetkin [36]
;
Seyed Mohammad,Baghbanian [37]
;
Rana,Karabudak [38]
;
Abdullah,Al-Asmi [39]
;
Gregor Brecl,Jakob [40]
;
Samia J,Khoury [41]
;
Masoud,Etemadifar [42]
;
Vincent,van Pesch [43]
;
Katherine,Buzzard [44]
;
Bruce,Taylor [45]
;
Helmut,Butzkueven [1]
;
Anneke,Van der Walt [46]
作者单位：
Department of Neuroscience, Central Clinical School, The Alfred, Melbourne, VIC, Australia.;Department of Neurology, The Alfred Hospital, 55 Commercial Road, Melbourne, 3004, Australia.
[1]
Department of Neuroscience, Central Clinical School, The Alfred, Melbourne, VIC, Australia.;Department of Neurology, The Alfred Hospital, 55 Commercial Road, Melbourne, 3004, Australia.;Royal Hobart Hospital, Hobart, Australia.
[2]
Department of Neuroscience, Central Clinical School, The Alfred, Melbourne, VIC, Australia.
[3]
Perron Institute for Neurological and Translational Science, The University of Western Australia, Perth, Australia.;Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, Australia.
[4]
Department of Neuroscience, MS Center, Neurology Unit, S. Maria Delle Croci Hospital, AUSL Romagna, Ravenna, Italy.;Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy.
[5]
Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia.;School of Medicine, University of Zagreb, Zagreb, Croatia.
[6]
Department of Neurology, Neuroimmunology Centre, Royal Melbourne Hospital, Melbourne, Australia.;CORe, Department of Medicine, University of Melbourne, Melbourne, Australia.
[7]
Department of Neurology, Neuroimmunology Centre, Royal Melbourne Hospital, Melbourne, Australia.
[8]
Hunter Medical Research Institute, University Newcastle, Newcastle, Australia.
[9]
Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Australia.;Department of Neurology, Monash Health, Clayton, Australia.
[10]
Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
[11]
Medical and Surgical Sciences, Universita Di Foggia, Foggia, Italy.
[12]
Department of Neurology, LR 18SP03, Clinical Investigation Centre Neurosciences and Mental Health, Razi University Hospital, Tunis, Tunisia.;Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
[13]
Multiple Sclerosis Centre, West-Tallinn Central Hospital, Tallinn, Estonia.
[14]
Department of Neurology, Centro de Esclerosis Múltiple (CEMHUN), Hospital Universitario Nacional de Colombia Bogota, Bogota, Colombia.;Departamento de Medicina InternaFacultad de Medicina, Universidad Nacional de Colombia, Bogota, Colombia.
[15]
Multiple Research Centre, Neuroscience Institute, Tehran University of Medical Science, Tehran, Iran.
[16]
Department of Neurology, Centro Hospitalar Universitario de Sao Joao, Porto, Portugal.
[17]
South Eastern HSC Trust, Belfast, UK.
[18]
St. Michael's Hospital, Toronto, Canada.
[19]
Department of Neurology, Concord Repatriation General Hospital, Sydney, Australia.
[20]
Translational Neuroimmunology Group, Kids Neuroscience Centre and Brain and Mind Centre, Concord Hospital, Sydney, Australia.
[21]
Neurology Department, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
[22]
Department of Neurology, School of Medicine and Koc University Research Center for Translational Medicine (KUTTAM), İstanbul, Turkey.
[23]
Izmir University of Economics, Medical Point Hospital, Izmir, Turkey.;Multiple Sclerosis Research Association, Izmir, Turkey.
[24]
Division of Neurology, Department of Medicine, Amiri Hospital, Sharq, Kuwait.
[25]
Department of Neuroscience, MS Center, Neurology Unit, S. Maria Delle Croci Hospital, AUSL Romagna, Ravenna, Italy.
[26]
Department of Neurology, University Hospital Ghent, Ghent, Belgium.
[27]
Department of Neurology, Hospital Universitario Virgen Macarena, Seville, Spain.
[28]
CHUM and Universite de Montreal, Montreal, Canada.
[29]
Immune Tolerance Laboratory Ingham Institute and Department of Medicine, UNSW, Sydney, Australia.
[30]
Department of Neuroscience, Hospital Germans Trias I Pujol, Badalona, Spain.
[31]
Centro Sclerosi Multipla, UOC Neurologia, Azienda Ospedaliera Per L'Emergenza Cannizzaro, Catania, Italy.
[32]
University of Queensland, Brisbane, Australia.;Royal Brisbane and Women's Hospital, Brisbane, Australia.
[33]
Azienda Ospedaliera Di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.
[34]
Department of Neurology, Galdakao-Usansolo University Hospital, Osakidetza-Basque Health Service, Galdakao, Spain.
[35]
Department of Neurology, Erciyes University, Kayseri, Turkey.
[36]
Neurology Department, Booalisina Hospital, Mazandaran University of Medical Sciences, Sari, Iran.;Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
[37]
Department of Neurological Sciences, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.;Neuroimmunology Unit, Koşuyolu Hospitals, Istanbul, Turkey.
[38]
College of Medicine & Health Sciences and Sultan Qaboos University Hospital, Sultan Qaboos University, Al-Khodh, Oman.
[39]
Department of Neurology, University Medical Centre Ljubljana, Ljubljana, Slovenia.;Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
[40]
Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon.
[41]
Neurology, Dr. Etemadifar MS Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
[42]
Department of Neurology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
[43]
Department of Neurosciences, Box Hill Hospital, Box Hill, Australia.
[44]
Royal Hobart Hospital, Hobart, Australia.
[45]
Department of Neuroscience, Central Clinical School, The Alfred, Melbourne, VIC, Australia. anneke.vanderwalt@monash.edu.;Department of Neurology, The Alfred Hospital, 55 Commercial Road, Melbourne, 3004, Australia. anneke.vanderwalt@monash.edu.
[46]
医学主题词
人类(Humans);纵向研究(Longitudinal Studies);男(雄)性(Male);多发性硬化(Multiple Sclerosis);女(雌)性(Female);成年人(Adult);中年人(Middle Aged);免疫抑制剂(Immunosuppressive Agents);免疫因子类(Immunologic Factors);克利屈滨(Cladribine)
DOI
10.1007/s00415-024-12518-7
PMID
38935148
发布时间
2024-11-16
- 浏览0
Journal of neurology
Journal of neurology
5813-5824页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
